Skip to main content
. 2021 Mar 15;13(6):1304. doi: 10.3390/cancers13061304

Figure 1.

Figure 1

Treatment options for fit patients with resectable gastric or gastroesophageal junction adenocarcinoma. EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; FLOT, 5-fluorouracil/leucovorin, oxaliplatin, and docetaxel; LVI, lymphovascular invasion; MDT, multidisciplinary team; MSI, microsatellite instability.